Stock Analysis on Net
Stock Analysis on Net

Cytokinetics Inc. (NASDAQ:CYTK)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Decomposing ROE involves expressing net income divided by shareholders’ equity as the product of component ratios.

Two-Component Disaggregation of ROE

Cytokinetics Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Sep 30, 2023 — = -71.12% × —
Jun 30, 2023 — = -69.19% × —
Mar 31, 2023 — = -48.41% × —
Dec 31, 2022 — = -38.33% × —
Sep 30, 2022 — = -26.22% × —
Jun 30, 2022 -193.80% = -27.98% × 6.93
Mar 31, 2022 -221.62% = -30.09% × 7.36
Dec 31, 2021 -88.29% = -25.59% × 3.45
Sep 30, 2021 -91.83% = -27.63% × 3.32
Jun 30, 2021 -944.65% = -27.60% × 34.22
Mar 31, 2021 -198.96% = -23.39% × 8.51
Dec 31, 2020 -112.27% = -23.85% × 4.71
Sep 30, 2020 -76.20% = -24.04% × 3.17
Jun 30, 2020 — = -60.39% × —
Mar 31, 2020 — = -51.34% × —
Dec 31, 2019 — = -41.99% × —
Sep 30, 2019 — = -62.71% × —
Jun 30, 2019 — = -55.48% × —
Mar 31, 2019 -3,124.97% = -53.06% × 58.90
Dec 31, 2018 -409.84% = -50.33% × 8.14
Sep 30, 2018 — = — × 4.42
Jun 30, 2018 — = — × 3.29
Mar 31, 2018 — = — × 2.81

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

Three-Component Disaggregation of ROE

Cytokinetics Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Sep 30, 2023 — = -6,739.96% × 0.01 × —
Jun 30, 2023 — = -5,422.19% × 0.01 × —
Mar 31, 2023 — = -439.35% × 0.11 × —
Dec 31, 2022 — = -411.21% × 0.09 × —
Sep 30, 2022 — = -190.34% × 0.14 × —
Jun 30, 2022 -193.80% = -142.85% × 0.20 × 6.93
Mar 31, 2022 -221.62% = -396.22% × 0.08 × 7.36
Dec 31, 2021 -88.29% = -305.72% × 0.08 × 3.45
Sep 30, 2021 -91.83% = -1,061.13% × 0.03 × 3.32
Jun 30, 2021 -944.65% = -269.48% × 0.10 × 34.22
Mar 31, 2021 -198.96% = -230.55% × 0.10 × 8.51
Dec 31, 2020 -112.27% = -228.00% × 0.10 × 4.71
Sep 30, 2020 -76.20% = -209.88% × 0.11 × 3.17
Jun 30, 2020 — = -751.39% × 0.08 × —
Mar 31, 2020 — = -592.61% × 0.09 × —
Dec 31, 2019 — = -452.93% × 0.09 × —
Sep 30, 2019 — = -378.69% × 0.17 × —
Jun 30, 2019 — = -308.72% × 0.18 × —
Mar 31, 2019 -3,124.97% = -303.70% × 0.17 × 58.90
Dec 31, 2018 -409.84% = -337.41% × 0.15 × 8.14
Sep 30, 2018 — = — × — × 4.42
Jun 30, 2018 — = — × — × 3.29
Mar 31, 2018 — = — × — × 2.81

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

Five-Component Disaggregation of ROE

Cytokinetics Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Sep 30, 2023 — = — × — × -6,379.13% × 0.01 × —
Jun 30, 2023 — = — × — × -5,142.17% × 0.01 × —
Mar 31, 2023 — = — × — × -415.26% × 0.11 × —
Dec 31, 2022 — = — × — × -390.68% × 0.09 × —
Sep 30, 2022 — = — × — × -179.16% × 0.14 × —
Jun 30, 2022 -193.80% = — × — × -133.63% × 0.20 × 6.93
Mar 31, 2022 -221.62% = — × — × -372.85% × 0.08 × 7.36
Dec 31, 2021 -88.29% = — × — × -282.38% × 0.08 × 3.45
Sep 30, 2021 -91.83% = — × — × -985.77% × 0.03 × 3.32
Jun 30, 2021 -944.65% = — × — × -241.71% × 0.10 × 34.22
Mar 31, 2021 -198.96% = — × — × -203.44% × 0.10 × 8.51
Dec 31, 2020 -112.27% = — × — × -199.41% × 0.10 × 4.71
Sep 30, 2020 -76.20% = — × — × -182.86% × 0.11 × 3.17
Jun 30, 2020 — = — × — × -686.93% × 0.08 × —
Mar 31, 2020 — = — × — × -549.74% × 0.09 × —
Dec 31, 2019 — = — × — × -428.28% × 0.09 × —
Sep 30, 2019 — = — × — × -362.39% × 0.17 × —
Jun 30, 2019 — = — × — × -295.86% × 0.18 × —
Mar 31, 2019 -3,124.97% = — × — × -291.87% × 0.17 × 58.90
Dec 31, 2018 -409.84% = — × — × -325.36% × 0.15 × 8.14
Sep 30, 2018 — = — × — × — × — × 4.42
Jun 30, 2018 — = — × — × — × — × 3.29
Mar 31, 2018 — = — × — × — × — × 2.81

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

Two-Component Disaggregation of ROA

Cytokinetics Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Sep 30, 2023 -71.12% = -6,739.96% × 0.01
Jun 30, 2023 -69.19% = -5,422.19% × 0.01
Mar 31, 2023 -48.41% = -439.35% × 0.11
Dec 31, 2022 -38.33% = -411.21% × 0.09
Sep 30, 2022 -26.22% = -190.34% × 0.14
Jun 30, 2022 -27.98% = -142.85% × 0.20
Mar 31, 2022 -30.09% = -396.22% × 0.08
Dec 31, 2021 -25.59% = -305.72% × 0.08
Sep 30, 2021 -27.63% = -1,061.13% × 0.03
Jun 30, 2021 -27.60% = -269.48% × 0.10
Mar 31, 2021 -23.39% = -230.55% × 0.10
Dec 31, 2020 -23.85% = -228.00% × 0.10
Sep 30, 2020 -24.04% = -209.88% × 0.11
Jun 30, 2020 -60.39% = -751.39% × 0.08
Mar 31, 2020 -51.34% = -592.61% × 0.09
Dec 31, 2019 -41.99% = -452.93% × 0.09
Sep 30, 2019 -62.71% = -378.69% × 0.17
Jun 30, 2019 -55.48% = -308.72% × 0.18
Mar 31, 2019 -53.06% = -303.70% × 0.17
Dec 31, 2018 -50.33% = -337.41% × 0.15
Sep 30, 2018 — = — × —
Jun 30, 2018 — = — × —
Mar 31, 2018 — = — × —

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

Four-Component Disaggregation of ROA

Cytokinetics Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Sep 30, 2023 -71.12% = — × — × -6,379.13% × 0.01
Jun 30, 2023 -69.19% = — × — × -5,142.17% × 0.01
Mar 31, 2023 -48.41% = — × — × -415.26% × 0.11
Dec 31, 2022 -38.33% = — × — × -390.68% × 0.09
Sep 30, 2022 -26.22% = — × — × -179.16% × 0.14
Jun 30, 2022 -27.98% = — × — × -133.63% × 0.20
Mar 31, 2022 -30.09% = — × — × -372.85% × 0.08
Dec 31, 2021 -25.59% = — × — × -282.38% × 0.08
Sep 30, 2021 -27.63% = — × — × -985.77% × 0.03
Jun 30, 2021 -27.60% = — × — × -241.71% × 0.10
Mar 31, 2021 -23.39% = — × — × -203.44% × 0.10
Dec 31, 2020 -23.85% = — × — × -199.41% × 0.10
Sep 30, 2020 -24.04% = — × — × -182.86% × 0.11
Jun 30, 2020 -60.39% = — × — × -686.93% × 0.08
Mar 31, 2020 -51.34% = — × — × -549.74% × 0.09
Dec 31, 2019 -41.99% = — × — × -428.28% × 0.09
Sep 30, 2019 -62.71% = — × — × -362.39% × 0.17
Jun 30, 2019 -55.48% = — × — × -295.86% × 0.18
Mar 31, 2019 -53.06% = — × — × -291.87% × 0.17
Dec 31, 2018 -50.33% = — × — × -325.36% × 0.15
Sep 30, 2018 — = — × — × — × —
Jun 30, 2018 — = — × — × — × —
Mar 31, 2018 — = — × — × — × —

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

Disaggregation of Net Profit Margin

Cytokinetics Inc., decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Sep 30, 2023 -6,739.96% = — × — × -6,379.13%
Jun 30, 2023 -5,422.19% = — × — × -5,142.17%
Mar 31, 2023 -439.35% = — × — × -415.26%
Dec 31, 2022 -411.21% = — × — × -390.68%
Sep 30, 2022 -190.34% = — × — × -179.16%
Jun 30, 2022 -142.85% = — × — × -133.63%
Mar 31, 2022 -396.22% = — × — × -372.85%
Dec 31, 2021 -305.72% = — × — × -282.38%
Sep 30, 2021 -1,061.13% = — × — × -985.77%
Jun 30, 2021 -269.48% = — × — × -241.71%
Mar 31, 2021 -230.55% = — × — × -203.44%
Dec 31, 2020 -228.00% = — × — × -199.41%
Sep 30, 2020 -209.88% = — × — × -182.86%
Jun 30, 2020 -751.39% = — × — × -686.93%
Mar 31, 2020 -592.61% = — × — × -549.74%
Dec 31, 2019 -452.93% = — × — × -428.28%
Sep 30, 2019 -378.69% = — × — × -362.39%
Jun 30, 2019 -308.72% = — × — × -295.86%
Mar 31, 2019 -303.70% = — × — × -291.87%
Dec 31, 2018 -337.41% = — × — × -325.36%
Sep 30, 2018 — = — × — × —
Jun 30, 2018 — = — × — × —
Mar 31, 2018 — = — × — × —

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).